Beam Therapeutics Inc.

Beam Therapeutics Inc.verified

BEAM

Price:

$27.06

Market Cap:

$2.23B

Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen receptor T cell for the treatment of relapsed/refractory T-cell acute lymphoblastic leukemia; and BEAM-301, a liver-targeted development candidate for the treatment of patients with Glycogen Storage Disease Type Ia. It also develops therapies for alpha-1 antitrypsin deficiency; ocular diseases; and other liver, muscle, and central nervous system disor...[Read more]

Industry

Biotechnology

IPO Date

2020-02-06

Stock Exchange

NASDAQ

Ticker

BEAM

The ROE as of November 2024 (TTM) for Beam Therapeutics Inc. (BEAM) is -16.22%

According to Beam Therapeutics Inc.’s latest financial reports and current stock price. The company's current ROE is -16.22%. This represents a change of 239.30% compared to the average of -4.78% of the last 4 quarters.

Beam Therapeutics Inc. (BEAM) Historical ROE (quarterly & annually)

How has BEAM ROE performed in the past?

The mean historical ROE of Beam Therapeutics Inc. over the last ten years is -23.94%. The current -16.22% ROE has changed -32.22% with respect to the historical average. Over the past ten years (40 quarters), BEAM's ROE was at its highest in in the March 2018 quarter at 246.44%. The ROE was at its lowest in in the March 2021 quarter at -47.71%.

Quarterly (TTM)
Annual

Average

-23.94%

Median

-41.29%

Minimum

-104.42%

Maximum

191.30%

Beam Therapeutics Inc. (BEAM) ROE by Quarter and Year

Discovering the peaks and valleys of Beam Therapeutics Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 34.38%

Maximum Annual ROE = 191.30%

Minimum Annual Increase = -144.95%

Minimum Annual ROE = -104.42%

Quarterly (TTM)
Annual
YearROEChange
2023-13.50%-62.42%
2022-35.94%-12.96%
2021-41.29%-60.46%
2020-104.42%34.38%
2019-77.71%-9.64%
2018-85.99%-144.95%

Beam Therapeutics Inc. (BEAM) Average ROE

How has BEAM ROE performed in the past?

The current ROE of Beam Therapeutics Inc. (BEAM) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-30.24%

5-year avg

-54.57%

10-year avg

-23.94%

Beam Therapeutics Inc. (BEAM) ROE vs. Peers

How is BEAM’s ROE compared to its peers?

Beam Therapeutics Inc.’s ROE is greater than Editas Medicine, Inc. (-80.13%), greater than CRISPR Therapeutics AG (-12.15%), greater than Caribou Biosciences, Inc. (-45.46%), greater than Verve Therapeutics, Inc. (-35.23%), greater than Intellia Therapeutics, Inc. (-51.97%), greater than Fate Therapeutics, Inc. (-44.09%), greater than Prime Medicine, Inc. (-113.34%), greater than Vertex Pharmaceuticals Incorporated (-2.88%), greater than Ginkgo Bioworks Holdings, Inc. (-86.10%), greater than Sana Biotechnology, Inc. (-71.60%),

Build a custom stock screener for Beam Therapeutics Inc. (BEAM) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Beam Therapeutics Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Beam Therapeutics Inc. (BEAM) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Beam Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Beam Therapeutics Inc.'s ROE?

How is the ROE calculated for Beam Therapeutics Inc. (BEAM)?

What is the highest ROE for Beam Therapeutics Inc. (BEAM)?

What is the 3-year average ROE for Beam Therapeutics Inc. (BEAM)?

What is the 5-year average ROE for Beam Therapeutics Inc. (BEAM)?

How does the current ROE for Beam Therapeutics Inc. (BEAM) compare to its historical average?